Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$5,718,015
+$876,688 QoQ
Shares Held
22,723
+2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#1,236
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Impact Capital Partners LLC holds $17,729,418 across 9 Drug Manufacturers - General names. ABBV ranks #2 (32.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,378 | $6,445,250 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
22,723 | $5,718,015 | |
| 3 | LLY |
ELI LILLY & Co
|
2,228 | $2,672,330 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,635 | $1,495,097 | |
| 5 | AZN |
Astrazeneca PLC
|
1,705 | $323,302 | |
| 6 | AMGN |
Amgen Inc
|
851 | $308,164 | |
| 7 | PFE |
Pfizer Inc
|
12,174 | $293,149 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,549 | $262,113 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,718,015 | 22,723 | Shares | Defined | 2026-07-14 | |
| 2026-03-31 | $4,841,327 | 22,260 | Shares | Defined | 2026-04-10 | |
| 2025-12-31 | $6,164,431 | 26,979 | Shares | Defined | 2026-01-07 | |
| 2025-09-30 | $6,115,202 | 26,411 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $4,542,307 | 24,471 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $5,057,184 | 24,137 | Shares | Defined | 2025-04-11 | |
| 2024-12-31 | $3,892,696 | 21,906 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||